|
| | Publication Year | Title | Author(s) |
| 1 | Nov-2023 | The frequency and nature of barriers to escalation of care in two Australian teaching hospitals. | Wright, Breanna; Plant, Bernice; Lennox, Alyse; Faulkner, Nicholas; Bragge, Peter; Doric, Andrea; Jones, Daryl A ; Leung, Christopher |
| 2 | 29-Jul-2022 | A critical evaluation of the role of iron overload in fatty liver disease. | Fernandez, Monique; Lokan, Julie ; Leung, Christopher ; Grigg, Andrew P |
| 3 | Jun-2020 | Hepatitis B virus activity is not associated with degree of liver steatosis in patients with Hepatitis B-related chronic liver disease. | Worland, Thomas ; Apostolov, Ross ; Asadi, Khashayar ; Leung, Christopher |
| 4 | 20-Sep-2019 | Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion. | Zhuang, Aowen; Yap, Felicia Y T; McCarthy, Domenica; Leung, Christopher ; Sourris, Karly C; Penfold, Sally A; Thallas-Bonke, Vicki; Coughlan, Melinda T; Schulz, Benjamin L; Forbes, Josephine M |
| 5 | 9-Jun-2018 | Exploring the feasibility of targeted chronic hepatitis B screening in the emergency department: A pilot study. | Brock, Catherine; Yi, Yuan; Papaluca, Timothy ; Lucas, Benjamin; Angus, Peter W ; Taylor, David McD ; Leung, Christopher |
| 6 | 27-Apr-2018 | Low Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients with Type 2 Diabetes Mellitus and NAFLD. | Bruinstroop, Eveline; Dalan, Rinkoo; Yang, Cao; Bee, Yong Mong; Chandran, Kurumbian; Cho, Li Wei; Soh, Shui Boon; Teo, Eng Kiong; Toh, Sue-Anne; Leow, Melvin Khee Shing; Sinha, Rohit A; Sadananthan, Suresh Anand; Michael, Navin; Stapleton, Heather; Leung, Christopher ; Angus, Peter W ; Patel, Sheila K ; Burrell, Louise M ; Chi, Lim Su; Fang, Sum Chee; Velan, S Sendhil; Yen, Paul M |
| 7 | 25-Sep-2017 | Increased liver AGEs induce hepatic injury mediated through an OST48 pathway. | Zhuang, Aowen; Yap, Felicia Yt; Bruce, Clinton; Leung, Christopher ; Plan, Manuel R; Sullivan, Mitchell A; Herath, Chandana; McCarthy, Domenica; Sourris, Karly C; Kantharidis, Phillip; Coughlan, Melinda T; Febbraio, Mark A; Hodson, Mark P; Watt, Matthew J; Angus, Peter W ; Schulz, Benjamin L; Forbes, Josephine M |
| 8 | Jun-2017 | Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness. | Knowles, Simon R; Austin, David W; Sivanesan, Suresh; Tye-Din, Jason; Leung, Christopher ; Wilson, Jarrad; Castle, David J; Kamm, Michael A; Macrae, Finlay; Hebbard, Geoff |
| 9 | 21-Sep-2016 | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease | Leung, Christopher ; Herath, Chandana B; Jia, Zhiyuan; Andrikopoulos, Sofianos; Brown, Bronwyn E; Davies, Michael J; Rivera, Leni R; Furness, John B; Forbes, Josephine M; Angus, Peter W |
| 10 | Jul-2016 | The role of the gut microbiota in NAFLD | Leung, Christopher ; Rivera, L; Furness, John B; Angus, Peter W |
| 11 | 28-Jan-2015 | Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. | Leung, Christopher ; Yeoh, Sern Wei; Patrick, Desmond; Ket, Shara; Marion, Kaye; Gow, Paul J ; Angus, Peter W |
| 12 | 6-Dec-2013 | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | Leung, Christopher ; Herath, Chandana B; Jia, Zhiyuan; Goodwin, Michelle; Mak, Kai Yan; Watt, Matthew J; Forbes, Josephine M; Angus, Peter W |
| 13 | 1-Feb-2013 | Advanced glycation end products augment experimental hepatic fibrosis. | Goodwin, Michelle; Herath, Chandana B; Jia, Zhiyuan; Leung, Christopher ; Coughlan, Melinda T; Forbes, Josephine M; Angus, Peter W |
Loading...
2
0
20
0
false